[go: up one dir, main page]

LV10292A - Olbaltumvielas DNS vektori farmaceitiskas kompozicijas olbaltumvielu pielietojums kompozicija uzturam farmaceitiskas kompozicijas iegusanas panemiens bernu uztura iegusanas panemiens - Google Patents

Olbaltumvielas DNS vektori farmaceitiskas kompozicijas olbaltumvielu pielietojums kompozicija uzturam farmaceitiskas kompozicijas iegusanas panemiens bernu uztura iegusanas panemiens

Info

Publication number
LV10292A
LV10292A LV931005A LV931005A LV10292A LV 10292 A LV10292 A LV 10292A LV 931005 A LV931005 A LV 931005A LV 931005 A LV931005 A LV 931005A LV 10292 A LV10292 A LV 10292A
Authority
LV
Latvia
Prior art keywords
pharmaceutical composition
nutrition
bssl
protein
composition
Prior art date
Application number
LV931005A
Other languages
English (en)
Other versions
LV10292B (en
Inventor
Karl Gunnar Bjursell
Lars Gustav Blaeckberg
Peter Nils Ivar Carlsson
Curt Sven Magnus Enerbaeck
Carl Olof Edward Hernell
Jeanette Annika Nilsson
Thomas Olivercrona
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10292A publication Critical patent/LV10292A/lv
Publication of LV10292B publication Critical patent/LV10292B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LVP-93-1005A 1990-06-01 1993-07-30 Derivatives of human bile salt stimulated lipase and pharmaceutical compositions containing them LV10292B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products
PCT/SE1991/000381 WO1991018923A1 (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
LV10292A true LV10292A (lv) 1994-10-20
LV10292B LV10292B (en) 1995-08-20

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1005A LV10292B (en) 1990-06-01 1993-07-30 Derivatives of human bile salt stimulated lipase and pharmaceutical compositions containing them

Country Status (44)

Country Link
EP (1) EP0535048B1 (lv)
JP (1) JPH05507201A (lv)
KR (1) KR100212411B1 (lv)
CN (2) CN1075113C (lv)
AP (1) AP207A (lv)
AT (1) ATE151077T1 (lv)
AU (1) AU651979B2 (lv)
BG (1) BG61165B1 (lv)
CA (1) CA2083396C (lv)
CZ (1) CZ287470B6 (lv)
DE (1) DE69125489T2 (lv)
DK (1) DK0535048T3 (lv)
DZ (1) DZ1503A1 (lv)
EG (1) EG19937A (lv)
ES (1) ES2099159T3 (lv)
FI (1) FI114639B (lv)
GR (1) GR3023618T3 (lv)
HK (1) HK62497A (lv)
HR (1) HRP920771B1 (lv)
HU (1) HU215258B (lv)
IE (1) IE911844A1 (lv)
IL (1) IL98273A (lv)
IS (1) IS1751B (lv)
JO (1) JO1694B1 (lv)
LT (1) LT4020B (lv)
LV (1) LV10292B (lv)
MA (1) MA22166A1 (lv)
MY (1) MY111245A (lv)
NO (1) NO322962B1 (lv)
NZ (1) NZ238223A (lv)
PH (1) PH30761A (lv)
PL (1) PL166534B1 (lv)
PT (1) PT97836B (lv)
RO (1) RO114793B1 (lv)
RU (1) RU2140983C1 (lv)
SE (1) SE9001985D0 (lv)
SG (1) SG48078A1 (lv)
SK (1) SK281089B6 (lv)
TN (1) TNSN91041A1 (lv)
TW (1) TW221712B (lv)
UA (1) UA39165C2 (lv)
WO (1) WO1991018923A1 (lv)
YU (1) YU49138B (lv)
ZA (1) ZA913778B (lv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (en) * 2005-12-01 2008-09-03 University of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
DK2561069T3 (en) 2010-04-23 2017-05-01 Alexion Pharma Inc Enzyme for lysosomal storage disease
NZ608292A (en) 2010-09-09 2014-10-31 Synageva Biopharma Corp Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
CN103189070A (zh) 2010-10-21 2013-07-03 瑞典孤儿比奥维特鲁姆有限公司 增加人婴儿对不饱和脂肪酸之吸收的方法
RU2013123053A (ru) * 2010-10-21 2014-11-27 Сведиш Орфан Биовитрум Аб (Пабл) Способ увеличения скорости роста новорожденных детей
EP3642338B1 (en) * 2017-06-19 2022-04-27 Swedish Orphan Biovitrum AB (publ) Fusion protein with half-life extending polypeptide
US11987823B2 (en) 2019-08-30 2024-05-21 Societe Des Produits Nestle S.A. Engineered lipase variants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131418A1 (en) * 1983-07-01 1985-01-16 Celltech Limited Proteins, pharmaceutical compositons, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
YU49138B (sh) 2004-03-12
BG61165B1 (bg) 1997-01-31
FI114639B (fi) 2004-11-30
FI925453A0 (fi) 1992-11-30
AP207A (en) 1992-08-18
SE9001985D0 (sv) 1990-06-01
GR3023618T3 (en) 1997-08-29
AP9100270A0 (en) 1991-07-31
LTIP1736A (en) 1995-08-25
RU2140983C1 (ru) 1999-11-10
LT4020B (en) 1996-08-26
NO322962B1 (no) 2006-12-18
NO924528L (no) 1992-11-24
DZ1503A1 (fr) 2004-09-13
PT97836B (pt) 1998-11-30
PT97836A (pt) 1992-02-28
WO1991018923A1 (en) 1991-12-12
HK62497A (en) 1997-05-16
EP0535048A1 (en) 1993-04-07
TW221712B (lv) 1994-03-11
AU7964591A (en) 1991-12-31
EG19937A (en) 2000-12-31
LV10292B (en) 1995-08-20
RO114793B1 (ro) 1999-07-30
ES2099159T3 (es) 1997-05-16
AU651979B2 (en) 1994-08-11
CN1075113C (zh) 2001-11-21
CN1064313A (zh) 1992-09-09
IE911844A1 (en) 1991-12-04
SG48078A1 (en) 1998-04-17
DE69125489D1 (de) 1997-05-07
TNSN91041A1 (fr) 1992-10-25
NZ238223A (en) 1993-05-26
HU215258B (hu) 1998-11-30
IL98273A0 (en) 1992-06-21
IS3710A7 (is) 1991-12-02
JO1694B1 (en) 1992-08-09
HRP920771A2 (en) 1997-04-30
KR100212411B1 (en) 1999-08-02
CA2083396C (en) 2006-09-19
IL98273A (en) 2005-11-20
CA2083396A1 (en) 1991-12-02
MA22166A1 (fr) 1991-12-31
NO924528D0 (no) 1992-11-24
ATE151077T1 (de) 1997-04-15
PL166534B1 (pl) 1995-05-31
ZA913778B (en) 1992-02-26
CN1326782A (zh) 2001-12-19
YU95191A (sh) 1994-06-10
SK164491A3 (en) 1995-07-11
CZ287470B6 (cs) 2000-12-13
SK281089B6 (sk) 2000-11-07
EP0535048B1 (en) 1997-04-02
MY111245A (en) 1999-10-30
JPH05507201A (ja) 1993-10-21
HRP920771B1 (en) 1999-10-31
IS1751B (is) 2000-07-21
UA39165C2 (uk) 2001-06-15
DE69125489T2 (de) 1997-08-14
CZ164491A3 (cs) 1999-07-14
HUT63184A (en) 1993-07-28
FI925453L (fi) 1992-11-30
BG97123A (bg) 1993-12-24
HU9203774D0 (en) 1993-03-29
PH30761A (en) 1997-10-17
DK0535048T3 (da) 1997-09-29

Similar Documents

Publication Publication Date Title
LV10292A (lv) Olbaltumvielas DNS vektori farmaceitiskas kompozicijas olbaltumvielu pielietojums kompozicija uzturam farmaceitiskas kompozicijas iegusanas panemiens bernu uztura iegusanas panemiens
WO1998014592A3 (en) Telomerase reverse transcriptase
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
NO972801D0 (no) Imidazo (4,5-c) kinolinaminer
ATE115147T1 (de) Rekombinantes alveolares oberflächenaktives protein.
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
CA2102693A1 (en) Protein formulation comprising growth hormone
GR3000350T3 (en) Hair cosmetics
NO960309L (no) Agonister og antagonister for humaninterleukin-10
DE3583547D1 (de) Kosmetisches mittel.
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
AU2670495A (en) Ifn-beta liquid formulations
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
EP0317279A3 (en) Peptides for use in the purification of factor viii
DK0550783T3 (da) Anvendelse af diolestere i hunde- og kattefoder
IT9022342A0 (it) Formulazioni di amminoacidi liofilizzati contenenti glutammina, loro preparazione ed uso nell'alimentazione parenterale
Gharavi Molecular cloning of the human lipoxygenase gene
WO2001036458A3 (en) Drosophila ced-6 homologue
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции